IMMUNOTHERAPY OF METASTATIC MELANOMA WITH INTERLEUKIN-2

被引：0
|
作者：
PACIUCCI, PA
机构：
[1] CUNY MT SINAI SCH MED,DEPT NEOPLAST DIS,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,JEANNE B LAMBERT LAB CANC RES,NEW YORK,NY 10029
来源：
MOUNT SINAI JOURNAL OF MEDICINE | 1992年 / 59卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：238 / 243
页数：6
相关论文
共 50 条
  • [41] SEQUENTIAL CHEMOIMMUNOTHERAPY WITH CISPLATIN, INTERLEUKIN-2, AND INTERFERON ALFA-2A FOR METASTATIC MELANOMA
    KHAYAT, D
    BOREL, C
    TOURANI, JM
    BENHAMMOUDA, A
    ANTOINE, E
    RIXE, O
    VUILLEMIN, E
    BAZEX, PA
    THILL, L
    FRANKS, R
    AUCLERC, G
    SOUBRANE, C
    BANZET, P
    WEIL, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) : 2173 - 2180
  • [42] Subcutaneous recombinant interleukin-2 plus chemotherapy with cisplatin and dacarbazine in metastatic melanoma
    Guida, M
    Latorre, A
    Mastria, A
    DeLena, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (04) : 730 - 733
  • [43] COMBINED INTERLEUKIN-2 AND OKT3 THERAPY IN THE TREATMENT OF METASTATIC MELANOMA
    HOLLINGWORTH, J
    HORSBURGH, T
    VEITCH, PS
    BELL, PRF
    KHANNA, S
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (05) : 847 - 850
  • [44] Activity of Continuous Infusion plus Pulse Interleukin-2 with Famotidine in Metastatic Melanoma
    Quan, Walter D. Y., Jr.
    Quan, Francine M.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (01) : 1 - 5
  • [45] CUTANEOUS SIDE-EFFECTS ASSOCIATED WITH INTERLEUKIN-2 ADMINISTRATION FOR METASTATIC MELANOMA
    WOLKENSTEIN, P
    CHOSIDOW, O
    WECHSLER, J
    GUILLAUME, JC
    LESCS, MC
    BRANDELY, M
    AVRIL, MF
    REVUZ, J
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 28 (01) : 66 - 70
  • [46] Effect of interleukin-2 on parameters related to metastatic activity in human melanoma cells
    Díaz-Pérez, JL
    García-Vázquez, MD
    Michelena, TL
    Garcí, JG
    Pinedo, MD
    Belloso, RI
    Muhialdin, JS
    Díaz-Ramón, L
    Boyano, MD
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (06) : 1465 - 1465
  • [47] SEQUENTIAL DACARBAZINE CISPLATIN AND INTERLEUKIN-2 IN METASTATIC MELANOMA - IMMUNOLOGICAL EFFECTS OF THERAPY
    REDMAN, BG
    FLAHERTY, L
    CHOU, TH
    NAKEFF, A
    PILLOTE, K
    KAPLAN, J
    [J]. JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02): : 147 - 151
  • [48] Does continuous-infusion interleukin-2 increase survival in metastatic melanoma?
    Dillman, RO
    O'Connor, AA
    Simpson, L
    Barth, NM
    VanderMolen, LA
    Vanderplas, P
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02): : 141 - 145
  • [49] Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma
    Hughes, Tasha
    Klairmont, Matthew
    Sharfman, William H.
    Kaufman, Howard L.
    [J]. CANCER BIOLOGY & THERAPY, 2021, 22 (10-12) : 513 - 526
  • [50] Combination therapy with interferon-gamma and interleukin-2 for the treatment of metastatic melanoma
    Kim, CJ
    Taubenberger, JK
    Simonis, TB
    White, DE
    Rosenberg, SA
    Marincola, FM
    [J]. JOURNAL OF IMMUNOTHERAPY, 1996, 19 (01) : 50 - 58
12345